Patients with both high FAP+ fibroblasts and SPP1+ macrophages exhibited the shortest PFS compared with the signature combination groups, suggesting that these two cell types can synergistically promote tumor progression (Fig. 5b). Here, SPP1 is linked to neoplasm.